Get startedLog in
    Picture of Windtree Therapeutics logo

    WINT — Windtree Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Windtree Announces Positive Topline Results From Its Phase 2 Seismic Study Of Istaroxime In Early Cardiogenic Shock

    Picture of Windtree Therapeutics logoWindtree Therapeutics
    20/04/2022 12:02
    April 20 (Reuters) - Windtree Therapeutics Inc  WINT.O :
    * WINDTREE ANNOUNCES POSITIVE TOPLINE RESULTS FROM ITS PHASE
2
SEISMIC STUDY OF ISTAROXIME IN EARLY CARDIOGENIC SHOCK
    * WINDTREE THERAPEUTICS INC - STUDY MET ITS PRIMARY ENDPOINT
IN
SBP PROFILE OVER SIX HOURS

Source text for Eikon:  ID:nGNX91XwWs 
Further company coverage:  WINT.O

    Recent news on Windtree Therapeutics

    See all news